|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: ALEXION PHARMACEUTICALS INC, 10-K, EX-23.1, 2000-10-06 |
Next: ALEXION PHARMACEUTICALS INC, 10-K, EX-99.1, 2000-10-06 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET, THE STATMENT OF OPERATIONS, AND THE STATEMENT OF CASH FLOWS AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> JUL-31-2000
<PERIOD-START> AUG-01-1999
<PERIOD-END> JUL-31-2000
<CASH> 91,858
<SECURITIES> 82,671
<RECEIVABLES> 5,095
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 180,080
<PP&E> 13,029
<DEPRECIATION> (4,816)
<TOTAL-ASSETS> 192,702
<CURRENT-LIABILITIES> 7,178
<BONDS> 123,920
0
0
<COMMON> 2
<OTHER-SE> 61,604
<TOTAL-LIABILITY-AND-EQUITY> 192,702
<SALES> 0
<TOTAL-REVENUES> 21,441
<CGS> 0
<TOTAL-COSTS> 44,362
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 2,694
<INCOME-PRETAX> (20,227)
<INCOME-TAX> 0
<INCOME-CONTINUING> (20,227)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (20,227)
<EPS-BASIC> (1.45)
<EPS-DILUTED> (1.45)
</TABLE>
|
|